Articles https://doi.org/10.1038/s41551-019-0416-1 1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. 2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3Children’s Research Institute, Departments of Pediatrics, Neuroscience, and Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA. 4Department of Otolaryngology, University of Texas Southwestern

RESEARCH ON SYMPTOM MONITORING AND PREVENTIVE COGNITIVE THERAPY FOR PERINATAL DEPRESSION The Department of Psychiatry at the University of Texas Southwestern Medical Center is conducting research sponsored by the National Institute of Mental Health (NIMH) on perinatal depression, aiming to develop a treatment program for conceiving or pregnant women at risk for depressive relapse and recurrence. We are recruiting women with a history of depression who are planning to become

Theranostics 2020, Vol. 10, Issue 7 http://www.thno.org 3340 Theranostics 2020; 10(7): 3340-3350. doi: 10.7150/thno.41239 Research Paper Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles Zachary T. Bennett1, Qiang Feng1, Justin A. Bishop2, Gang Huang1, Baran D. Sumer3, and Jinming Gao1,3 1. Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 2

Mitral Valve Phase Contrast Imaging Is a More Reproducible Method of Determining Cardiac Rest Periods for Whole-Heart Coronary Magnetic Resonance Angiography in Congenital Heart Disease than 4 Chamber Cine. Maria Batsis, MD; F. Gerald Greil, MD, PhD; Animesh Tandon, MD, MS; Tarique Hussain, MD, PhD University of Texas Southwestern Medical Center, Dallas, TX, USA; Children’s Medical Center of Dallas Background Whole heart coronary magnetic resonance angiography (CMRA) offers detailed

NATURE BIOMEDICAL ENGINEERING 1, 0006 (2016) | DOI: 10.1038/s41551-016-0006 | www.nature.com/natbiomedeng 1 ARTICLES PUBLISHED: 19 DECEMBER 2016 | VOLUME: 1 | ARTICLE NUMBER: 0006 A transistor-like pH nanoprobe for tumour detection and image-guided surgery Tian Zhao1 †, Gang Huang1, Yang Li1, Shunchun Yang1, Saleh Ramezani2, Zhiqiang Lin1, Yiguang Wang1, Xinpeng Ma1, Zhiqun Zeng1, Min Luo1, Esther de Boer3, Xian-Jin Xie4, Joel Thibodeaux5, Rolf A. Brekken6, Xiankai Sun2, Baran D. Sumer7

CURRICULUM VITAE Jef Karel De Brabander, Ph.D. Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX-75390-9038 Voice: (214) 648-7808, Fax: (214) 648-0320, E-mail: jef.debrabander@utsouthwestern.edu Education December 1993 Ph.D. in Chemistry (Highest Honors), University of Gent, Belgium July 1987 B.Sc. in Chemistry (Distinction), University of Gent, Belgium Professional Experience 2011- Julie and Louis

Harold C. Simmons Comprehensive Cancer Center Bioinformatics Data Science Shared Resource Data Science Fellowship Agreement SCCC-DSSR This agreement is between the parties named below and the Director of SCCC-DSSR, Professor Jeon Lee. By signing this document, awardees (and their mentors, if applicable) acknowledge and agree to abide by the fellowship conditions listed below. Fellowship Awardee (Full Name

• female • 20-40 years old • premenopausal You may be eligible for participation in a study on the role of obesity in Polycystic Ovarian Syndrome. Some compensation for participating in the study will be available. UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER We are conducting a study in body fat in women with clinical diagnosis of Polycystic Ovarian Syndrome. If you are: • female • 20-40 years old • premenopausal • healthy OR have a clinical diagnosis of

\ PEGSITACIANINE FOR THE SURGICAL DETECTION OF HEAD AND NECK CANCER PURPOSE INCLUSION DESIGN To investigate whether Pegsitacianine a fluorescent nanoparticle can image head and neck cancer and unknown primary head and neck cancer during surgery or biopsy. 1. Adults ≥ 18 years of age 2. Patients with stage 1-4 Head and Neck Squamous Cell Carcinoma (HNSCC) undergoing surgical excision 1. Phase 2 Clinical trial of Pegsitacianine, which is